This review demonstrates the pharmacological potential of Sodium New Houttuyfonate in antimicrobial and antitumor applications, highlighting its therapeutic implications.
Key Points
The aim is to summarize the pharmacological advances of Sodium New Houttuyfonate (SNH) as a multi-target therapeutic agent.
Conducted a comprehensive review of literature until December 2025.
Gathered data from PubMed, Web of Science, Scopus, and CNKI.
Focused on experimental studies related to SNH’s synthesis, bioactivities, and therapeutic potential.
SNH shows strong antibacterial and antifungal activity against drug-resistant pathogens.
Demonstrates antitumor activity in cancer models by regulating RNA networks and inducing apoptosis.
Functions as an immunoadjuvant, enhancing immune responses in vaccination settings.